- Home
- CYRX vs MRVI Comparison
CYRX vs MRVI Comparison
Compare CYRX & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- MRVI
- Stock Information
- Founded
- CYRX 1999
- MRVI 2014
- Country
- CYRX United States
- MRVI United States
- Employees
- CYRX N/A
- MRVI N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- CYRX Health Care
- MRVI Health Care
- Exchange
- CYRX Nasdaq
- MRVI Nasdaq
- Market Cap
- CYRX 277.5M
- MRVI 262.9M
- IPO Year
- CYRX N/A
- MRVI 2020
- Fundamental
- Price
- CYRX $7.07
- MRVI $1.98
- Analyst Decision
- CYRX Strong Buy
- MRVI Hold
- Analyst Count
- CYRX 8
- MRVI 9
- Target Price
- CYRX $10.75
- MRVI $6.54
- AVG Volume (30 Days)
- CYRX 451.2K
- MRVI 1.7M
- Earning Date
- CYRX 05-07-2025
- MRVI 05-12-2025
- Dividend Yield
- CYRX N/A
- MRVI N/A
- EPS Growth
- CYRX N/A
- MRVI N/A
- EPS
- CYRX N/A
- MRVI N/A
- Revenue
- CYRX $232,134,000.00
- MRVI $259,185,000.00
- Revenue This Year
- CYRX N/A
- MRVI N/A
- Revenue Next Year
- CYRX $8.19
- MRVI $14.23
- P/E Ratio
- CYRX N/A
- MRVI N/A
- Revenue Growth
- CYRX 11.75
- MRVI N/A
- 52 Week Low
- CYRX $4.58
- MRVI $1.67
- 52 Week High
- CYRX $16.89
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- CYRX 67.38
- MRVI 43.17
- Support Level
- CYRX $5.43
- MRVI $1.96
- Resistance Level
- CYRX $6.00
- MRVI $2.16
- Average True Range (ATR)
- CYRX 0.47
- MRVI 0.13
- MACD
- CYRX 0.16
- MRVI 0.04
- Stochastic Oscillator
- CYRX 91.53
- MRVI 47.67
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.